Y Chabbert
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 2%
Papers in
-
- Antibiotic Resistance in Bacteria 23
-
- Antibiotic Use and Resistance 8
Y Chabbert
65 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 93
- Molecular Medicine 623
- Endocrinology 187
- Applied Microbiology and Biotechnology 44
- Infectious Diseases 383
- Clinical Biochemistry 116
Countries citing papers authored by Y Chabbert
This map shows the geographic impact of Y Chabbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Chabbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Chabbert more than expected).
Fields of papers citing papers by Y Chabbert
This network shows the impact of papers produced by Y Chabbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Chabbert. The network helps show where Y Chabbert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Y Chabbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 13 | |
| 2 | 1988 | 12 | |
| 3 | 1978 | 19 | |
| 4 | Groupes d'incompatibilité des plasmides r chez les souches de Salmonella épidémiques. | 1977 | 4 |
| 5 | Carte génétique et strucutre chez Escherichia coli K12 d'un plasmide de résistance isolé de Salmonella ordonez | 1975 | 14 |
| 6 | Sensibilité des streptocoques A et B vis-à-vis de la pénicilline G, de la pénicilline V, de l'ampicilline et di l'amoxicilline | 1975 | 7 |
| 7 | Caractérisation d'un facteur de résistance transférable de Vibrio cholerae biotype eltor | 1973 | 6 |
| 8 | 1971 | 25 | |
| 9 | [Rifampicin: a bacteriostatic and bactericidal agent]. | 1969 | 4 |
| 10 | 1968 | 236 | |
| 11 | Variations due to Acriflavin and Transduction of Resistance to Kanamycin and Chloramphenicol in Staphylococci. | 1964 | 1 |
| 12 | [The sensitivity to antibio otics of Pseudomonas, Achromobacter and "B5W-Bacterium anitratum"]. | 1961 | 1 |
| 13 | [In vivo determination of the bacterial action of antibiotics in renal staphylococcal infection of the mouse]. | 1957 | 3 |
| 14 | [Novobiocin; its experimental activity in vitro and in vivo; its value in severe staphylococcal diseases]. | 1956 | 3 |
| 15 | 1956 | 7 | |
| 16 | [Development of antibiotic resistance in bacteria isolated from city patients in Paris from 1949 to 1954]. | 1955 | 3 |
| 17 | In Vitro Studies of Spira-mycin. Activity, Resistance, Antibiogram, Concentrations in Body Fluids. | 1955 | 7 |
| 18 | Determination of Bacterial Sensitivity to Sulphonamides by a Dry Disk Method. | 1953 | 2 |
| 19 | [Combinations of antibiotics; their bacteriostatic and bactericide potency; clinical applications]. | 1953 | 2 |
| 20 | Observed Evolution of Types of Resistance to Antibiotics among Pathogenic Staphylococci. | 1952 | 2 |
About Y Chabbert
Y Chabbert is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Endocrinology and Infectious Diseases, having authored 75 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (23 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Antimicrobial Resistance in Staphylococcus (12 papers), Antibiotic Use and Resistance (8 papers), Mycobacterium research and diagnosis (7 papers), Streptococcal Infections and Treatments (6 papers), Historical Medical Research and Treatments (6 papers) and Salmonella and Campylobacter epidemiology (5 papers). The work is most often cited by research in Molecular Medicine (623 citations), Endocrinology (187 citations), Applied Microbiology and Biotechnology (44 citations), Infectious Diseases (383 citations) and Clinical Biochemistry (116 citations). Y Chabbert has collaborated with scholars based in France and Japan. Frequent co-authors include D. H. Bouanchaud, M Scavizzi, A Jaffé, T Horodniceanu, G Gerbaud, G Bieth, J. F. Acar, E Derlot, Jean-Claude Patte and Lydie Bougueleret. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, The Journal of Antibiotics, Chemotherapy and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.